Abstract
Background
Prazosin is an α1 adrenoceptor antagonist used in pharmacotherapy for the treatment of hypertension. Prazosin alters lipid metabolism in vivo, but the involved mechanism is not fully understood. In this study, we investigated the mechanism underlying the alteration of lipid metabolism. We show that the prazosin-stimulated release of hepatic triacylglyceride lipase (HTGL) from primary cultured rat hepatocytes involved Ca2+/calmodulin-dependent protein kinase II (CaMK-II) activation.
Methods
Primary cultured rat hepatocytes were incubated with prazosin and other agents. The hepatocytes were used in the CaMK-II and protein kinase A (PKA) activity assay. The supernatant was used in the HTGL activity assay and western blotting.
Results
Prazosin-stimulated HTGL release was suppressed by the inositol triphosphate receptor inhibitor xestospongin C and by the calmodulin inhibitor trifluoperazine but not by the protein kinase C inhibitor chelerythrine chloride or a diacylglycerol kinase inhibitor (R59949). Furthermore, the calmodulin-dependent protein kinase II (CaMK-II) activity in prazosin-treated hepatocytes increased in a time- and dose-dependent manner. The cAMP-dependent PKA activity of prazosin-stimulated hepatocytes was suppressed by a phospholipase C (PLC) inhibitor (U-73122), trifluoperazine, and a CaMK-II inhibitor (KN-93).
Conclusions
These results suggested that prazosin-stimulated HTGL release from hepatocytes was caused by activation of PKA associated with stimulation of CaMK-II activity through a signal cascade from PLC.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Nilsson-Ehle P, Garfinkel AS, Schotz MC. Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem 1980;49(1):667–93.
Landin B, Nilsson A, Twu JS, Schotz MC. A role for hepatic lipase in chylomicron and high density lipoprotein phospholipid metabolism. J Lipid Res 1984;25(6): 559–563.
Connelly PW. The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta 1999;286(1–2):243–55.
Perret B, Mabile L, Martinez L, Tercé F, Barbaras R, Collet X. Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 2002;43(8): 1163–1169.
Kuusi T, Nikklä EA, Virtanen I, Kinnunen PK. Localization of the heparin-releasable lipase in situ in the rat liver. Biochem J 1979;181(1):245–6.
Armenia A, Munavvar AS, Abdullah NA, Helmi A, Johns EJ. The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats. Br J Pharmacol 2004;142(4):719–26.
Lepor H. Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia. Prostate Suppl 1990;17(S3):75–84.
Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, et al. Effects of long-term prazosin therapy on lipoprotein metabolism in hypertensive patients. Am J Med 1984;76(2A):113–6.
Krupp MN, Hoover KW, Valentine JJ. Effects of Doxazosin and other antihypertensives on serum lipid levels and lipoprotein lipase in the C57BR/cdj mouse. J Cardiovasc Pharmacol 1989;13(2):S11–8. discussion, S18-9.
Belahsen R, Deshaies Y. Alpha-1 adrenergic blockade interacts with dietary carbohydrates on triacylglycerol metabolism in rats. J Nutr 1993;123(3): 520–528.
Notake M, Kondo Y, Nomura H, Nakano K, Hosoki K, Miyazaki M. Up-regulation of hepatic gene expression by monatepil, a novel calcium antagonist, in high cholesterol diet-fed Japanese monkeys. Am J Hypertens 1994;7(11):1026–30.
Nakamura T, Kerakawati R, Morita T. Prazosin stimulates the release of hepatic triacylglycerol lipase caused from primary-culture rat hepatocytes. J Health Sci 2010;56(4):462–6.
Nakamura T, Morita T. Adenosine 3′,5′-monophosphate involvement in hepatic triacylglyceride lipase release from prazosin-stimulated primary cultured rat hepatocytes. Biol Pharm Bull 2014;37(6):922–5.
Wisse E. Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells. J Ultrastruct Res 1974;46(3):393–426.
Krauss RM, Windmueller HG, Levy RI, Fredrickson DS. Selective measurement of two different triglyceride lipase activities in rat post heparin plasma. J Lipid Res 1973;14(3):286–95.
Sacks DB, Mazus B, Joyal JL. The activity of calmodulin is altered by phosphorylation: modulation of calmodulin function by the site of phosphate incorporation. Biochem J 1995;312(1):197–204.
Kruglov EA, Gautam S, Guerra MT, Nathanson MH. Type 2 inositol 1,4, 5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes. Hepatology 2011;54(5):1790–9.
Björnsson OG, Bourgeois CS, Gibbons GF. Varying very low-density lipoprotein secretion of rat hepatocytes by altering cellular levels of calcium and the activity of protein kinase C. Eur J Clin Invest 1998;28(9):720–9.
Hashimoto N, Maruyama T, Toda G, Ikeda Y, Sugiyama Y, Oka H. Effects of calmodulin antagonists on secretion of bile and bile acid. Gastroenterol Jpn 1987;22(2):194–202.
Baldanzi G, Pietronave S, Locarno D, Merlin S, Porporato P, Chianale F, et al. Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi’s sarcoma cells. Cancer Sci 2011;102(7): 1329–1336.
Ishitoya J, Yamakawa A, Takenawa T. Translocation of diacylglycerol kinase in response to chemotactic peptide and phorbol ester in neutrophils. Biochem Biophys Res Commun 1987;144(2):1025–30.
Tagashira H, Nakahigashi S, Kerakawati R, Motoyashiki T, Morita T. Involvement of Ca2+/calmodulin-dependent protein kinase II in heparin-stimulated release of hepatic lipase activity from rat hepatocytes. Biol Pharm Bull 2005;28(3):409–12.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, T., Kamishikiryo, J. & Morita, T. Prazosin-stimulated release of hepatic triacylglyceride lipase from primary cultured rat hepatocytes is involved in the regulation of cAMP-dependent protein kinase through activation of the Ca2+/calmodulin-dependent protein kinase-II. Pharmacol. Rep 68, 649–653 (2016). https://doi.org/10.1016/j.pharep.2016.02.001
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2016.02.001